Zenotech Laboratories

Zenotech Laboratories Accounts Payable

The Accounts Payable of Zenotech Laboratories (532039.BO) as of Nov 22, 2026 is 36.96 M INR. In the previous year, Accounts Payable was 25.24 M INR — a change of 46.47% (higher).

Accounts Payable

36.96 MINR

YoY

46.47%

Last updated:

Accounts Payable of Zenotech Laboratories is 2026 36.96 M INR. Accounts Payable of Zenotech Laboratories was 2025 25.24 M INR. It decreases by 46.47% higher compared to the previous year.

The Zenotech Laboratories Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2019
41.15 M INR
Jan 1, 2020
46.02 M INR
Jan 1, 2021
19.22 M INR
Jan 1, 2022
20.66 M INR
Jan 1, 2023
34.77 M INR
Jan 1, 2024
28.06 M INR
Jan 1, 2025
25.24 M INR
Jan 1, 2026
36.96 M INR
The Zenotech Laboratories Accounts Payable history
YEARAccounts PayableYoY
36.96 MINR+46.47%
25.24 MINR-10.05%
28.06 MINR-19.31%
34.77 MINR+68.27%
20.66 MINR+7.51%
19.22 MINR-58.24%
46.02 MINR+11.83%
41.15 MINR-23.98%
54.13 MINR+5.43%
51.34 MINR+20.79%
42.51 MINR+117.84%
19.51 MINR-41.66%
33.45 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenotech Laboratories Stock analysis

What does Zenotech Laboratories do? Zenotech Laboratories Ltd manufactures and markets pharmaceutical products, specializing in oncology, biotechnology, and general injectables. The company operates from a manufacturing facility in Turkapally village, Shamirpet Mandal, Telangana, producing specialty generic injectables for the pharmaceutical sector. Its products are sold to healthcare providers and distributors within the pharmaceutical industry, targeting markets that require specialized injectable solutions. The firm's business model focuses on the production and distribution of generic injectables, leveraging its facility in Telangana to serve both domestic and international markets. By concentrating on oncology and biotechnology injectables, Zenotech addresses specific medical needs, generating revenue through the sale of these high-demand pharmaceutical products to hospitals, clinics, and pharmaceutical distributors. Zenotech Laboratories Ltd's revenue streams come from the sale of its specialty generic injectables, including oncology and biotechnology products, to healthcare institutions and distribution networks. The company's manufacturing capabilities in Telangana support its role as a supplier in the pharmaceutical supply chain, with a focus on injectable formulations that cater to critical healthcare applications. Zenotech Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenotech Laboratories stock

Accounts Payable of Zenotech Laboratories is 36.96 M INR in 2026.

Accounts Payable of Zenotech Laboratories changed from 25.24 M INR to 36.96 M INR, representing a 46.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Zenotech Laboratories since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Zenotech Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Zenotech Laboratories

All Key Metrics — Zenotech Laboratories